Impact of Postoperative Changes in Brain Anatomy on Target Volume Delineation for High-Grade Glioma

Author:

Dejonckheere Cas Stefaan1ORCID,Thelen Anja2,Simon Birgit3,Greschus Susanne4,Köksal Mümtaz Ali1ORCID,Schmeel Leonard Christopher1ORCID,Wilhelm-Buchstab Timo5,Leitzen Christina1

Affiliation:

1. Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany

2. Faculty of Medicine, University Bonn, 53127 Bonn, Germany

3. Department of Radiology, University Hospital Bonn, 53127 Bonn, Germany

4. Department of Radiology, Waldkrankenhaus, 53177 Bonn, Germany

5. Radiation Oncology Bonn-Rhein-Sieg, 53115 Bonn, Germany

Abstract

High-grade glioma has a poor prognosis, and radiation therapy plays a crucial role in its management. Every step of treatment planning should thus be optimised to maximise survival chances and minimise radiation-induced toxicity. Here, we compare structures needed for target volume delineation between an immediate postoperative magnetic resonance imaging (MRI) and a radiation treatment planning MRI to establish the need for the latter. Twenty-eight patients were included, with a median interval between MRIs (range) of 19.5 (8–50) days. There was a mean change in resection cavity position (range) of 3.04 ± 3.90 (0–22.1) mm, with greater positional changes in skull-distant (>25 mm) resection cavity borders when compared to skull-near (≤25 mm) counterparts (p < 0.001). The mean differences in resection cavity and surrounding oedema and FLAIR hyperintensity volumes were −32.0 ± 29.6% and −38.0 ± 25.0%, respectively, whereas the mean difference in midline shift (range) was −2.64 ± 2.73 (0–11) mm. These data indicate marked short-term volumetric changes and support the role of an MRI to aid in target volume delineation as close to radiation treatment start as possible. Planning adapted to the actual anatomy at the time of radiation limits the risk of geographic miss and might thus improve outcomes in patients undergoing adjuvant radiation for high-grade glioma.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference38 articles.

1. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010;Ostrom;Neuro-Oncology,2013

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma;Warren;N. Engl. J. Med.,2005

3. Glioblastoma multiforme: State of the art and future therapeutics;Wilson;Surg. Neurol. Int.,2014

4. Glioblastoma: Overview of Disease and Treatment;Davis;Clin. J. Oncol. Nurs.,2016

5. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment;Hanif;Asian Pac. J. Cancer Prev.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3